According to a new report from Allied Market Research, global medical tourism is projected to reach $143.8 billion by 2022. This expansion is driven by increasing demand for more affordable and accessible medical care outside patients’ home countries. Factors such as rising cancer rates, a growing number of neurological conditions that require specialist care, and stress-related illnesses are prompting more people to seek treatment abroad where costs can be lower and wait times shorter.
North America and the Asia-Pacific region lead the medical tourism market, supported by competitive pricing and quality care in destinations such as Mexico, Thailand, Malaysia, India, and Singapore. The LAMEA region—comprising Latin America, the Middle East, and Africa—is also emerging as a significant player, with improving treatment outcomes and facilities. As these regions expand their offerings, specialized medical tourism travel agencies are proliferating to market destinations, coordinate logistics, and assist patients with arranging medical services, travel, and recovery plans.
The report forecasts robust growth over the next six years, with a compound annual growth rate (CAGR) for global medical tourism of 15.7%. Segments expected to grow even faster include medical tourism for cancer treatment, projected to increase by 16%, and for neurological treatment, projected to grow by 16.2%. These trends reflect both the rising prevalence of complex health conditions worldwide and the increasing willingness of patients to travel for specialized, cost-effective care.
As medical tourism expands, patients and providers are focusing more on transparency, accreditation, and coordination of care. Improved international standards, better information about treatment outcomes, and enhanced collaboration between foreign providers and patients’ home physicians are helping to reduce risks and improve continuity of care. While cost remains a key motivation, factors such as shorter wait times, access to advanced technologies, and the availability of specialist expertise are equally influential in patients’ decisions to pursue treatment abroad.
Healthcare systems, insurers, and policymakers are taking note of these shifts. Some insurers and employers are beginning to include medical travel options in benefits packages, while governments are investing in healthcare infrastructure and marketing to attract international patients. These developments aim to balance quality and affordability while ensuring patient safety and post-treatment follow-up.
Overall, the global medical tourism market is poised for substantial growth as more patients explore cross-border care for a range of conditions. Continued improvements in treatment success rates, combined with the expansion of services that support patient travel and recovery, will likely sustain demand and encourage further investment in this sector.